Well Cell Global
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus (NCT07187479) | Well Cell Global | 2025-10-14 |
Track Well Cell Global automatically
Every clearance here is in the API, with alerts when new ones post.